Grupo para el estudio de la salud cardiometabólica (GESCAMET)
GESCAMET
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von University of Texas Southwestern Medical Center (1)
2021
-
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults with Overweight or Obesity: The STEP 4 Randomized Clinical Trial
JAMA - Journal of the American Medical Association, Vol. 325, Núm. 14, pp. 1414-1425